# FDA 483 - Gehring-Montgomery, Inc. - February 09, 2024

Source: https://www.globalkeysolutions.net/records/483/gehring-montgomery-inc/823a6afe-5743-4330-b75e-a5fa6838d74d

> FDA 483 for Gehring-Montgomery, Inc. on February 09, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Gehring-Montgomery, Inc.
- Inspection Date: 2024-02-09
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: Gehring-Montgomery, Inc. in Warminster, PA, a packer, was cited for three observations during an FDA inspection. The firm failed to adequately investigate and remediate quality issues with components, lacked established recall procedures for distributed products, and did not provide CGMP training to its employees. These issues indicate significant deficiencies in quality control and regulatory compliance.

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/brandy-n-lepage/41e679e3-cc2a-4361-bf89-26acbd7deaf8)

Company: https://www.globalkeysolutions.net/companies/gehring-montgomery-inc/c0814822-3417-453f-a990-e9babc6b2523

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8